A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients

Summary

The purpose of this study is to determine the best dose of nebulized arformoterol, a quick onset but long acting beta agonist, for use in treating acute bronchospasm in asthmatics presenting to the the Emergency Department. Also this study will evaluate the side effect and safety profile of arformoterol when used in this situation.

Timeline

Start

2009-01

Primary completion

2009-11

Completion

2009-11

Outcome

Outcome not reported

Stopped (Enrollment): “Unable to enroll r/t study design \& staffing issues. The trial terminated.”

Drugs

Indications